Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Sondrio

10 clinical trials in Sondrio, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Sondrio at a glance
10
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

10 trials in Sondrio

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Seagen Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Arcagy Gineco
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Fondazione Italiana Linfomi Ets
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bicalutamide
  • Sponsor:Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Sulodexide
  • Sponsor:Fondazione Arianna Anticoagulazione
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bendamustine
  • Sponsor:Fondazione Italiana Linfomi Ets
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Neratinib
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Crizotinib
  • Sponsor:Xcovery Holding Co. LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Osimertinib
  • Sponsor:AstraZeneca AB

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Sondrio

What the registry says about research in the country

01 Oncology - Gastrointestinal

Research focusing on advanced treatments for rectal cancer and colorectal cancer, including innovative combination therapies. Studies evaluate the effectiveness of neoadjuvant treatments and targeted therapies for improved patient outcomes.

  • Locally advanced rectal cancer treatment
  • HER2+ colorectal cancer therapy
  • Combination chemotherapy approaches

Novel therapeutic combinations including aspirin and metformin are being investigated alongside standard treatments.

02 Oncology - Respiratory

Groundbreaking research in lung cancer treatments, particularly focusing on both small cell and non-small cell variants. Studies evaluate targeted therapies and novel drug combinations.

  • Small Cell Lung Cancer treatment
  • NSCLC targeted therapy
  • Post-surgical treatment optimization

Investigations include innovative treatments like lurbinectedin and osimertinib for different stages of lung cancer.

03 Oncology - Other

Comprehensive studies in various cancer types including breast cancer, prostate cancer, and ovarian cancer. Research focuses on targeted therapies and treatment optimization.

  • HER2+ breast cancer management
  • Follicular Lymphoma treatment
  • Advanced ovarian cancer therapy

Trials evaluate new therapeutic approaches including immunotherapy and radiation therapy protocols.

04 Cardiovascular

Important research in venous thromboembolism prevention and treatment, particularly focused on elderly patients. Studies examine new therapeutic approaches for preventing recurrence.

  • VTE prevention strategies
  • Elderly patient care
  • Blood clot prevention

Investigations include novel treatments like Sulodexide for preventing thrombotic episodes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.